Abstract
The growth of a 3-methylcholanthrene-induced fibrosarcoma of C3H mice was inhibited by aspirin and indomethacin. While the tumour contained relatively high concentrations of PGE2-like material, that were markedly diminished by indomethacin treatment, our results did not confirm the recently proposed hypothesis that the anti-tumour effect arises from a restoration of depressed immune function. For example, mice that had completely eliminated their tumours under indomethacin administration were not immune to rechallenge. The tumour-bearing animals were not non-specifically immunodepressed, as their splenic PFC responses against SRBC were enhanced. However, while indomethacin augmented the PFC response in normal mice, this adjuvant effect was depressed in tumour-bearing animals. The spleen-cell PHA responses of tumour bearers were severely depressed, and such cells suppressed the PHA response of normal cells. Only after prolonged indomethacin treatment did animals (with comparable tumour burdens) show weak PHA responses and somewhat diminished suppressive activity. Possible alternative mechanisms, such as direct cytotoxicity, or inhibition of inflammation, phosphodiesterase activity, blood coagulation or calcium availability were not implicated (nor definitively excluded) in the anti-tumour effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Lynch, N., Castes, M., Astoin, M. et al. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer 38, 503–512 (1978). https://doi.org/10.1038/bjc.1978.237
Issue Date:
DOI: https://doi.org/10.1038/bjc.1978.237
This article is cited by
-
Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
Cell Death & Disease (2019)
-
A history of exploring cancer in context
Nature Reviews Cancer (2018)
-
ASS bei mutiertem PIK3CA hoch effektiv
Info Onkologie (2013)
-
Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps Trial
American Journal of Gastroenterology (2011)
-
The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT
Oncogene (2002)